Hasselbalch, H.; Skov, V.; Kjær, L.; Larsen, M.K.; Knudsen, T.A.; Lucijanić, M.; Kusec, R.
Recombinant Interferon-β in the Treatment of Polycythemia Vera and Related Neoplasms: Rationales and Perspectives. Cancers 2022, 14, 5495.
https://doi.org/10.3390/cancers14225495
AMA Style
Hasselbalch H, Skov V, Kjær L, Larsen MK, Knudsen TA, Lucijanić M, Kusec R.
Recombinant Interferon-β in the Treatment of Polycythemia Vera and Related Neoplasms: Rationales and Perspectives. Cancers. 2022; 14(22):5495.
https://doi.org/10.3390/cancers14225495
Chicago/Turabian Style
Hasselbalch, Hans, Vibe Skov, Lasse Kjær, Morten Kranker Larsen, Trine A. Knudsen, Marko Lucijanić, and Rajko Kusec.
2022. "Recombinant Interferon-β in the Treatment of Polycythemia Vera and Related Neoplasms: Rationales and Perspectives" Cancers 14, no. 22: 5495.
https://doi.org/10.3390/cancers14225495
APA Style
Hasselbalch, H., Skov, V., Kjær, L., Larsen, M. K., Knudsen, T. A., Lucijanić, M., & Kusec, R.
(2022). Recombinant Interferon-β in the Treatment of Polycythemia Vera and Related Neoplasms: Rationales and Perspectives. Cancers, 14(22), 5495.
https://doi.org/10.3390/cancers14225495